Xilio Therapeutics (XLO) Stock Chart & Stock Price History $0.69 0.00 (0.00%) As of 07/3/2025 03:58 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Xilio Therapeutics Stock Price Performance The Xilio Therapeutics (XLO) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 19.70%, with a year-to-date return of -27.43%. In the past month, the stock has increased 4.07%, reflecting recent market activity. As of the latest close, Xilio Therapeutics traded at $0.69 with a market cap of $35.88 million and volume of 151,718 shares. Receive XLO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Xilio Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+2.62%1 Month Performance+4.07%3 Month Performance+1.96%Year-To-Date Performance-27.43%1 Year Performance-19.70% XLO Stock Chart for Friday, July, 4, 2025 XLO Chart by TradingView Xilio Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/03/2025$0.69$0.69$0.70$0.67151,718 shs$35.88 million07/02/2025$0.69$0.69$0.70$0.68142,469 shs$35.88 million07/01/2025$0.68$0.69+1.93%$0.70$0.66395,828 shs$35.88 million06/30/2025$0.68$0.68+0.68%$0.68$0.66381,095 shs$35.21 million06/27/2025$0.68$0.68-0.62%$0.69$0.66345,928 shs$34.97 million06/26/2025$0.68$0.68-0.42%$0.68$0.67289,522 shs$35.19 million06/25/2025$0.66$0.68+3.33%$0.69$0.66330,222 shs$35.34 million06/24/2025$0.67$0.66-1.43%$0.67$0.65625,920 shs$34.20 million06/23/2025$0.69$0.67-2.69%$0.69$0.66750,299 shs$34.69 million06/20/2025$0.66$0.69+4.22%$0.70$0.67620,233 shs$35.65 million Get the Latest News and Ratings for XLO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Xilio Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 06/19/2025$0.66$0.66$0.69$0.66600,174 shs$34.21 million06/18/2025$0.67$0.66-0.68%$0.69$0.66600,174 shs$34.21 million06/17/2025$0.69$0.67-3.05%$0.70$0.66331,616 shs$34.44 million06/16/2025$0.66$0.69+3.56%$0.69$0.65329,962 shs$35.52 million06/13/2025$0.68$0.66-3.10%$0.69$0.66374,539 shs$34.30 million06/12/2025$0.69$0.68-1.36%$0.69$0.67448,639 shs$35.40 million06/11/2025$0.70$0.69-1.00%$0.70$0.68435,978 shs$35.89 million06/10/2025$0.70$0.70$0.70$0.67629,731 shs$36.25 million06/09/2025$0.70$0.70$0.71$0.69682,942 shs$36.25 million06/06/2025$0.68$0.70+3.20%$0.74$0.67888,736 shs$36.25 million06/05/2025$0.67$0.68+1.86%$0.68$0.64633,214 shs$35.12 million06/04/2025$0.68$0.67-1.48%$0.70$0.65825,611 shs$34.48 million06/03/2025$0.70$0.68-3.46%$0.71$0.652.29 million shs$35.00 million06/02/2025$1.13$0.70-37.99%$0.78$0.695.45 million shs$36.25 million Related Companies FATE Stock Chart KYTX Stock Chart BDTX Stock Chart VXRT Stock Chart LXEO Stock Chart LYEL Stock Chart BYSI Stock Chart NMRA Stock Chart NKTX Stock Chart FTLF Stock Chart Receive XLO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Xilio Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:XLO) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Xilio Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Xilio Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
